PRLD — Prolight Diagnostics AB (publ) Income Statement
0.000.00%
Last trade - 00:00- SEK277.33m
- SEK261.59m
- 10
- 15
- 73
- 20
Annual income statement for Prolight Diagnostics AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 10 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | — | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | — | — | 21.9 | 12.6 | 17.2 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 4.18 | 6.97 | 10.5 | 136 | 27.3 |
| Operating Profit | -4.18 | -6.97 | -10.5 | -136 | -27.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -4.3 | -6.86 | -10.2 | -135 | -26.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.3 | -6.86 | -10.2 | -135 | -26.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -4.3 | -6.86 | -10.2 | -135 | -26.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4.3 | -6.86 | -10.2 | -135 | -26.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.029 | -0.046 | -0.036 | -0.064 | -0.046 |
| Dividends per Share |